Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ZymoGenetics ZGEN -- Ignore unavailable to you. Want to Upgrade?

To: DewDiligence_on_SI who wrote (155)	3/12/2009 10:18:16 AM
From: tuck	Read Replies (1) \| Respond to of 210

>>On March 9, 2009, ZymoGenetics, Inc. (the "Company") received a milestone payment in the amount of $20 million from Bristol-Myers Squibb Company ("BMS") under the previously announced global collaboration with BMS for PEG-Interferon lambda. This brings the total milestone payments from BMS for the first quarter 2009 to $105 million.<< From an 8-K filed this morning. I guess they are calling the $85 million upfront a milestone. Don't think this should trigger another accounting quiz, though. Cheers, Tuck